Ultrasound common hepatic artery denervation (CHA-D) as a novel neuromodulatory strategy for cardiovascular-kidney-metabolic syndrome: first-in-human experience - Top-Institutions - MDSpire

Ultrasound common hepatic artery denervation (CHA-D) as a novel neuromodulatory strategy for cardiovascular-kidney-metabolic syndrome: first-in-human experience

  • By

  • Mert Tokcan

  • Franciska Diana Wolter

  • Mathias Hohl

  • Peter Fries

  • Thorsten Kessler

  • Saarraaken Kulenthiran

  • Michael Böhm

  • June 3, 2026

  • 0 min

Share

Top Institutions in Cardiology

Brief introduction explaining scope and methodology.

  • #1

    Stanford Health Care – Stanford Hospital
    Stanford Health Care – Stanford Hospital

    Stanford, California

    Key Differentiators

    • Cardiology

  • #2

    Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical Center

    Boston, Massachusetts

    Key Differentiators

    • Cardiology

Original Source(s)

Ultrasound common hepatic artery denervation (CHA-D) as a novel neuromodulatory strategy for cardiovascular-kidney-metabolic syndrome: first-in-human experience

  • by Mert Tokcan, Franciska Diana Wolter, Mathias Hohl, Peter Fries, Thorsten Kessler, Saarraaken Kulenthiran, Michael Böhm

  • June 3, 2026

Related Content

Less Sitting in Pregnancy Tied to Lower Risk

Pregnant patients who sat less and moved more at light intensity had a lower risk of adverse outcomes in a prospective cohort study, but the findings do not prove causation.

Medical Oddities: Can a Home Be Preventive Care?

This week’s medical plot twists involved ants, architecture, and auditory hallucinations.

VSMCs and the immune microenvironment: a multidimensional regulatory network driving vascular injury and repair